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Abstract
Introduction: Warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome is a rare immunodeficien-
cy disorder with an autosomal-dominant pattern of inheritance and low fatality rate but significant lifelong morbidity. 
Materials and Methods: A 27-year-old mother of two children has been suffering from severe neutropenia and recurrent infec-
tions with the diagnosis of sporadic WHIM syndrome established by sequencing the CXCR4 gene and the finding of a het-
erozygous 1000 C→T nonsense mutation in the second CXCR4 exon. The first child was an apparently healthy boy delivered
at full term. Umbilical cord blood cells were obtained for genetic analysis. Peripheral blood cells were also analyzed at 8
months of life. Both analyses revealed the same mutation as that of his mother. The child was in a good condition, mani-
festing neutropenia without infections until 11 months of life. He subsequently developed pneumonia requiring a more
aggressive treatment. After that, the regular substitution of immunoglobulins (IVIGs) and G-CSF has been preventing seri-
ous infections. Six months ago the second boy was delivered who also demonstrated neutropenia without severe infections.
Genetic studies using cord blood and also peripheral blood cells in the fourth month showed an identical mutation of the
CXCR4 gene as in his mother. Moreover, the mother and her first son demonstrated monocytopenia. 
Results: The results indicate that genetic defects connected with WHIM syndrome may influence not only the granulocyte,
but also the monocytic lineage. Moreover, a perinatal diagnosis of WHIM syndrome made by sequencing the CXCR4 gene
should be performed in cases where either parent is known to be affected with this disease. 
Conclusions: This would facilitate an earlier detection of the deficiency in children, thereby allowing a more comprehensive
follow-up and administration of appropriate therapy.
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INTRODUCTION
Myelokathexis was introduced by Zeulzer [22] to
describe a new form of chronic granulocytopenia char-
acterized by an excessive bone marrow retention of
peculiar senescent granulocytes with hypersegmented
nuclear lobes. Later, the WHIM acronym was used to
describe patients with viral warts, hypogammaglobuline-
mia, infections, and myelokathexis [20]. Patients with
WHIM syndrome demonstrate a significant variability
of clinical symptoms [5]. Typically, severe non-cyclic
neutropenia without an increase in neutrophil count
during infections is observed [12, 13]. Quantitative and
qualitative leukocyte abnormalities also affect lympho-
cytes, with a reduction in circulating naive T cells and
memory B cells along with an increase in effector T cells
[6]. Moreover, lymphopenia is observed and the low
level of immunoglobulins implicates dysfunction ofB cells [4]. Patients suffer from recurrent bacterial infec-
tions affecting mainly the respiratory tract, skin, middle
ear, and gingiva which respond to antibiotic therapy.
The skin symptoms include human papilloma virus-
induced viral warts and erosions in the perianal region
which are resistant to therapy [5]. Epstein-Barr virus-
related B-cell lymphomas were described in two patients
[3, 9] and one patient with Kaposi sarcoma was report-
ed, which may suggest an increased risk of lymphoid
malignancies in WHIM syndrome, possibly induced by
Herpes viruses [3].
Family studies imply an autosomal-dominant inheri-
tance, while only one family was described with an
apparent autosomal-recessive mode, explained by
a paternal mosaicism [7]. The sporadic cases are rare
and have so far been described mostly in women [19].
The identification of 23 candidate genes was based on
whole autosome scans in three families with WHIM syn-
drome [7]. Mutations of the chemokine receptor
CXCR4 family gene were finally recognized in pivotal
association with this syndrome. Interactions between
CXCR4 and its ligand CXCL12 (stromal-derived factor
1) are crucial for fetal hematopoiesis and the trafficking
of hematopoietic cells [11, 16, 17]. All known CXCR4
mutations responsible for the WHIM phenotype are
heterozygous and affect the C-terminal cytoplasmic tail
of the protein with its truncation [6, 7, 17]. Subsequently,
T lymphocytes and mature granulocytes of WHIM
patients were shown to manifest an enhanced chemo-
tactic response to CXCL12, which may explain the trap-
ping of mature and senescent neutrophils within bone
marrow and enhanced removal of mature granulocytes
from the circulation [6]. The most frequent 1000
C→T mutation within the second CXCR4 exon leads to
altered receptor internalization and surface recovery
pathways [10]. However, the exact mechanisms linking
the profound abnormalities in CXCR4-CXCL12 signal-
ing and the WHIM phenotype are not entirely clear.
Moreover, in some WHIM patients a CXCR4 mutation
was excluded by sequencing the whole gene [2, 7]. 
The present report describes a sporadic case of
WHIM in a woman and the perinatal diagnosis of
WHIM syndrome in her two newborn sons. This spo-
radic case was proved by CXCR4 gene sequencing and
forensic analysis of the appropriate family short tandem
repeats (STRs) in three generations (grandparents,
mother and sons). The affected children were first diag-
nosed by genetic analysis of cord blood cells. Because of
the profound monocytopenia seen in the mother and
her first son, two main subpopulations of monocytes,
“classical” (CD14++CD16–) and “proinflammatory”
(CD14+CD16+), were also analyzed.
CASE PRESENTATION
A 23-year-old woman was referred to the hospital
for complex immunological tests with an initial diagno-
sis of common variable immunodeficiency (CVID)
because of hypogammaglobulinemia. She had been suf-
fering since childhood from recurrent sino-pulmonary
infections; first pneumonia occurred in the second
month of life with a white blood cell count of 0.3×109/l.
Leukopenia (0.86×109/l) was noted again during the
course of pneumonia at the age of 9 years. Upon diag-
nosing a non-cyclic leukopenia, therapy with subcuta-
neous (s.c.) GM-CSF or G-CSF was started. During the
previous 5 years she was treated with antibiotics because
of acute or exacerbant sinusitis and/or pneumonia.
Vaginal, but not skin, warts were observed when she was
20 years old. The family history was negative; her par-
ents, seven siblings, and other known relatives were free
of significant infections or warts.
On admission she was in good condition, with a mild
sinusitis. She responded poorly to antibiotics and G-CSF
therapy. Two trephine bone marrow biopsies were per-
formed, but the material was unsatisfactory to make
a diagnosis. The results of laboratory tests on admission
are shown in Table 1. Blood biochemistry and coagula-
tion were within normal ranges. There were no symp-
toms of autoimmune disease and autoantibodies were
absent. Ultasonography showed a slight splenomegaly
and X-ray and CT scans revealed bilateral shading of
the maxillary and frontal sinuses. The clinical history,
present symptoms, and an immunological workup sug-
gested a diagnosis of CVID. The therapy included intra-
venous immunoglobulin substitution with an initial dose
of 0.6 g/kg b.w. i.v. every 10 days followed by three infu-
sions of 0.4 g/kg every four weeks and G-CSF therapy (5
µg/kg s.c. every second day). During the two-year thera-
py, pulmonary infections became less frequent. After 18
months of treatment, the next trephine bone marrow
biopsy was performed. The morphological changes in
the bone marrow were typical (see below) and WHIM
syndrome was suspected. The diagnosis was confirmed
by DNA sequencing.
After two years of therapy she became pregnant. The
IVIG therapy was continued with a dosage of 0.6 g/kg
b.w. every three weeks, G-CSF was discontinued, and no
complications were observed during pregnancy. The
child was delivered by caesarian section at the 41st week
of pregnancy. Cord blood was taken for assessment of
the CXCR4 gene sequence. The boy had a birth-weight
of 2980 g and 8 points on the Apgar scale. No infections
were recorded in the neonatal period. DNA sequencing
studies showed a mutation similar to that found in the
mother. On the 14th day of life he was admitted to the
local hospital because of leukopenia, but neither G-CSF
therapy was introduce nor immunological tests per-
formed. At the age of 8 months, blood was taken for
genetic and immunological tests (Table 1). The initial
diagnosis of WHIM based on a cord blood assay was
confirmed by sequencing CXCR4-DNA isolated from
peripheral blood mononuclear cells. His general condi-
tion was good, his weight within the normal range for this
age. A flat angioma of the occipital region was noted.
The therapy included G-CSF (5 µg/kg s.c.) and IVIG
substitution (an initial dose of 0.25 g/kg b.w. followed by
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months he suffered from pneumonia with severe bron-
chospasms. The treatment with adrenalin, β2 mimetics
by inhalation, antibiotics, and steroids i.v. was effective.
Since then the boy remains healthy under constant
antiallergic therapy with preventive antibiotics, G-CSF
administered every 48 h, and IVIG every four weeks. 
The second boy was born with a weight of 2800 g and
9 points on the Apgar scale six months ago. The tests
using cord and peripheral blood (in the fourth month of
life) showed a mutation, identical to that of his mother,
of the CXCR4 gene and pronounced granulocytopenia
since birth. He is in good condition and on G-CSF and
IVIG (since the fourth month of life) therapy.
The presented children developed severe neutrope-
nia as the first symptom of WHIM syndrome. The
hypogammaglobulinemia was mild due to regular sub-
stitution of the mother during pregnancy. The appropri-
ate substitution with IVIG is believed to prevent or
diminish the severity of common infections; therefore
the early diagnosis of the children allowed treatment
according to the gradual development of clinical symp-
toms of WHIM syndrome. The first child received IVIG
from the eighth month of life, but despite this he devel-
oped severe pneumonia at the age of 11 months. After
that there were no serious infections despite persistent
neutropenia. It seems that IVIG substitution therapy
might have been introduced too late in this case.
Therefore, IVIG preparations were introduced in the
second son in the fourth month of life and until now (the
sixth month) he has not had severe infections.
Nevertheless, IVIG may not completely prevent, but
only significantly reduce, the incidence of respiratory
tract infections in immunodeficient children, as was
already shown in common variable immunodeficient
patients [14]. 
MATERIALS AND METHODS
Tissue samples
The blood and bone marrow samples from the moth-
er and blood samples from her parents were analyzed.
Cord and peripheral blood from the newborns was also
studied. Trephine bone marrow biopsies obtained from
the superior/inferior iliac crest of the mother using
Jamshidi needles were routinely fixed in buffered for-
malin, decalcified in acid-based medium (Shandon
TBD-1TM Decalcifier, Thermo Electronic Corporation,
Runcorn, UK), embedded in paraffin, and cut into 3- to
4-µm sections. The sections were stained with hema-
toxylin and eosin (H&E), Gomori silver, Giemsa, and
PAS methods. Bone marrow and peripheral blood
smears were routinely stained with May-Grunwald-
Giemsa. The parents and grandparents gave informed
consent to participate in the study, which was also
approved by the ethics review board of the Jagiellonian
University Medical College (permission No. KBET/107/
/B/2006).
M. Siedlar et al.: WHIM syndrome in mother and children 421
Table 1. The results of immunological tests in mother and her children with WHIM syndrome
Tests
Mother Boy 1 at 8 months of life Boy 2 at 4 months of life
tests results normal range tests results normal range tests results normal range
Granulocyte count (×109/l) 0.172 1.00–5.00 0.03 1.00–8.00 0.031 0.70–4.8
(17.2% of  (3.0% of (4.41% of 
normal value) normal value) normal value)
Lymphocyte count (×109/l) 0.662 1.00–4.00 2.0 3.40–10.50 2.852 3.30–10.3
(66% of  (58.8% of  (86.4% of
normal value) normal value) normal value)
Immunoglobulin level: 
IgG* g/l 4.30 7.00–16.00 1.67 2.76–7.44 2.50 2.66–7.01
IgA g/l 0.37 0.67–3.67 <0.06 0.13–0.81 0.07 0.07–0.37
IgM g/l 0.38 0.41–2.03 0.17 0.26–1.34 0.41 0.17–0.86
Lymphocytes:
B lymphocytes (CD19/µl) 9 110–570 80 610–2600 6 135–2000
T lymphocytes
CD3 (/µl) 171 1000–2200 1700 1900–5900 1053 2500–5500
CD4 (/µl) 57 530–1300 1320 1400–4300 806 1600–4000
CD8 (/µl) 93 330–920 320 500–1700 221 560–1700
NK (CD3–, CD16+/CD56+) 105 70–480 180 160–950 143 170–1100
(/µl)
Lymphoproliferation
anti-CD3 (SI) 1 >15 2 >15 92 >15
PHA (SI) 1 >15 1 >15 92 >15
*Before IVIG therapy.
Abbreviations: SI – stimulation index, PHA – phytohemagglutinin.Sequencing the CXCR4 gene
Both exons of the CXCR4 gene were sequenced to
look for mutations typical of WHIM syndrome. DNA
was extracted with a QIAmp DNA Mini Kit (Qiagen,
Germany) according to the manufacturer’s instructions.
PCR has been performed in a total volume of 20 ml,
with 100 ng of spectrophotometrically quantified DNA,
0.5 U of DNA polymerase (Promega, WI, USA), 1.5
mM MgCl2, 200 µM dNTP, and 0.5 µM of primers spe-
cific to the second exon of the CXCR4 gene (sense: 5’-
-TCC TCA TCC TGG CTT TCT TC, antisense: 5’-GCA
TAA ACA GCT GGG GAT CA). The PCR cycles were
1 min. at 95°C followed by 35 amplification cycles
(95°C for 45 s, 65°C for 45 s, 72°C for 1 min) and final
incubation at 4°C until the analysis commenced. The
PCR products were purified with a QIAquick Gel
Extraction Kit (Qiagen). 
Sequencing PCR was performed on the PCR prod-
ucts with using fluorescently labeled nucleotides (Big
Dye Terminator v3.1 Cycle Sequencing Kit, Applied
Biosystems, CA, USA) and exon-specific primers. The
PCR reaction parameters were as follows: reaction mix
– 10 ng DNA mixed with 8 µl Terminator Ready
Reaction Mix, 3.2 pM of each primer in a final volume
of 20 µl, PCR cycles – 1 min at 96°C followed by 25
amplification cycles (96°C for 10 s, 50°C for 5 s, 60°C for
4 min) and held at 4°C for purification.
The PCR products were purified by ethanol/EDTA
precipitation. The PCR products were dissolved in 25
µl of Template Suppression Reagent (Applied Bio-
systems), denatured, and run on the Applied Biosystems
310 sequencing apparatus and analyzed with the
Sequencing Analysis software (Applied Biosystems).
PCR-STR forensic analysis: family study
DNA was extracted from fresh whole blood of the
mother (WHIM syndrome) and her parents, as
described above. The test was performed with an
AmpFlSTR SGM Plus PCR Amplification Kit (Applied
Biosystems). PCR was performed using fluorescently
labeled primers. PCR reaction: 21 µl AmpFlSTR PCR
Reaction Mix, 1 µl polymerase Ampli Gold, 11
µl AmpFlSTR SGM Plus Primer Set, and 1–2.5 ng
DNA. The cycling conditions were 95°C for 11 min,
94°C for 1 min, 59°C for 1 min, 72°C for 1 min for 28
cycles, 60°C for 45 min, and final incubation at
25°C until ready for the analysis. The fluorescently
labeled PCR products were run on the Applied
Biosystems 310 sequencing apparatus and analyzed with
310 GeneScan3.1.2 software. 
Monocyte staining and analysis
The patients’ blood samples (200 µl) were washed
with 3 ml of 0.9% NaCl in polypropylene round-bottom
tubes (Falcon, Becton Dickinson Biosciences/
/Pharmingen: BD, Belgium) and 100 µl of the 200 µl of
cell suspension left after centrifugation was put into
a TruCount Tube with microbeads (BD). Then the cells
were stained on ice for 30 min with 5 µl of anti-CD45-
-APC (#340910, clone 2D1; BD), -HLA-DR-PerCP
(#347402, clone L243; BD), -CD14-FITC (#6603511,
clone MY4, Beckman-Coulter, Ireland), and -CD16-PE
(#332779, clone Leu11c; BD) monoclonal antibodies.
The samples were then treated with 400 µl of FACS
Lysing Solution (BD) for 3–5 min until erythrocytes
were lysed and the cells were immediately acquired on
a FACSCanto (BD) flow cytometer along with 10,000
beads, then analyzed with FACSDiva Software (BD,
CA, USA). The absolute numbers of CD14+CD16+ and
CD14++CD16– monocytes were calculated based on the
acquired bead count (10,000 in each sample) according
to the manufacturer’s instructions.
RESULTS
Bone marrow morphology
The bone marrow of the mother showed high cellu-
larity with an excess of myeloid cells, mostly hyperseg-
mented (senescent) neutrophils (Fig. 1). A uniform but
very narrow paratrabecular rim of promyelocytes was
present. Normal topography and undisturbed matura-
tion pattern of erythroid cells and megakaryocytes were
noted. There was no increase in lymphoid cells, mast
cells, or blasts. Also, minimal widespread reticulin fibro-
sis and distended blood vessels were seen. Bone marrow
and peripheral blood smears confirmed the characteris-
tic abnormalities of granulocytes, with a marked nuclear
hypersegmentation, thin and long chromatin filaments
connecting the nuclear lobes, and abnormal variability
in nuclear lobe sizes.
M. Siedlar et al.: WHIM syndrome in mother and children 422
Fig. 1. Highly cellular bone marrow biopsy of the WHIM-mother,
with increased mature neutrophil granulocytes showing prominent
nuclear segmentation. Inset: bone marrow smear reveals abnor-
mal nuclear segmentation patterns, including variability in nuclear
lobe sizes and unusually slender chromatin filaments connecting
the nuclear lobes.Genetic studies
No mutations on the first exon of the CXCR4 gene
were found. The studies concentrated on mutations on
the second exon associated with changes in the intracel-
lular tail domain essential for CXCR4 protein internal-
ization [7]. The only observed change was C→T het-
erozygosity at the base corresponding to position 1000
in the CXCR4-DNA second exon sequence leading to
a TGA stop codon. The observed nonsense mutation
may cause shortening of the cytoplasmatic tail of
CXCR4 protein. Such mutations were observed in the
mother and in both her sons in the cells taken from cord
and peripheral blood (Fig. 2). No such changes were
found in the grandparents (data not shown). Neither the
previously described [7] deletion of CT dinucleotide at
position 1016-1017 nor a G→T change at position 1027
were found in the cDNA sequences. Forensic analysis of
all 11 tested STR loci of the mother’s DNA revealed
alleles specific to her parents, corroborating the notion
of the spontaneous character of CXCR4 mutation in the
mother, which had occurred in chromosome 2 of one of
the parents of the proposita.
Immunological tests
The immunological tests showed a lowered level of
immunoglobulins of all classes in the mother and both
her sons (apart from IgM in the second son) and
markedly lowered absolute numbers of B (CD19+) lym-
phocytes in the mother and first son. Low numbers of
T lymphocytes in the mother and an inverse ratio of
CD4:CD8 were noted. Borderline numbers of T lym-
phocytes were observed in the children. There were no
responses to mitogen and CD3 stimulation in the moth-
er and first son (Table 1).
A low number of “proinflammatory” CD14+CD16+
monocytes in the mother (1 cell/µl; Fig. 3C) and in the
first son (10 cells/µl; Fig. 3E) was also observed. The
numbers of “classical” CD14++CD16– monocytes were
also decreased in both patients (59 cells/µl and 110
cells/µl, respectively; Figs. 3C, E). In our material the
numbers of CD14+CD16+ monocytes in healthy adult
volunteers (over 18 years old) were 66±31 cells/µl
(n=17) and in children 58±34 cells/µl (n=60). The
numbers of CD14++CD16– monocytes were, respective-
ly, 549±233 cells/µl and 430±158 cells/µl. The plots in
Figs. 3B and 3D are representative of age-matched
blood donors without immunodeficiency.
DISCUSSION
The clinical and laboratory findings of WHIM syn-
drome are very typical; however, in practice the correct
diagnosis may be delayed due to the rarity of the dis-
ease. In keeping with this, the reported case of sporadic
WHIM syndrome was not definitely diagnosed in the
mother until the age of 23 years, although the first symp-
toms occurred in the early childhood. The initial diag-
nosis of CVID was corrected after bone marrow exami-
nation, when hypercellularity with senescent granulo-
cytes was noted. Although the clinical course was mild,
the response to antibiotic therapy was limited. IVIG
substitution resulted in a decrease in the frequency of
infections. The response to G-CSF was rather poor;
neutropenia was observed, but it seemed clinically
silent. The mechanism of mobilization of neutrophil
release from the bone marrow via desensitization of
CXCR2 and increased signaling through the mutated
CXCR4 by the pathogen might be the explanation [4].
The sons, born with proper weights and without symp-
toms of the disease, were diagnosed with WHIM syn-
drome based on DNA sequencing of cord blood cells
and the presence of the mutation identical to that
observed in the mother. Although neutropenia was
observed, the first serious infection occurred in first son
at 11 months of life, despite IVIG substitution and G-
CSF therapy.
Myelokathexis is a morphological phenomenon
highly suggestive of WHIM syndrome, but it is probably
not entirely specific to this disease [15, 18]. A bone mar-
row examination of the mother revealed a limited
response to G-CSF (inadequate promyelocyte mobiliza-
tion), which is observed in patients with WHIM syn-
drome. The results of our study suggest that the defect
in granulocyte function in WHIM is not limited to the
postulated accumulation of senescent granulocytes in
the bone marrow, but may also affect their development
and maturation as well as the development and function
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Fig. 2. Electropherograms of a portion of the CXCR4 gene’s sec-
ond exon of the mother and her children with WHIM syndrome
show C→T heterozygosity at position 1000 in the cDNA sequence.
Cord blood and peripheral blood collected from the children in
the eighth (first son) and fourth (second son) months of life were
taken for the study.
mother
1st son 2nd son
cord blood
peripheral
blood
peripheral
bloodof T and B cells (low levels of lymphocytes and
immunoglobulins; Table 1) and perhaps monocytes.
The numbers of ”proinflammatory” CD14+CD16+
monocytes [20] and, to a lesser extent, “classical”
CD14++CD16– monocytes were significantly diminished
in the peripheral blood of the mother and her first son
in comparison with age-matched controls (Fig. 3 B–E).
The expression of CXCR4 molecule was higher on
monocytes obtained from WHIM patients than on those
from healthy persons (data not shown). This might be
associated with disturbed chemothaxis of monocytes
and/or granulocytes from niches with a high concentra-
tion of CXCL12 in the bone marrow as well as
macrophages in tissues. Together this suggests that the
proinflammatory response of macrophages, as well as
antigen presentation, may not be as effective as in
healthy individuals. Therefore, GM-CSF and/or IFN-γ
herapy may be superior to G-CSF substitution in
patients refractory to this cytokine, but this requires
additional studies.
The preference to female gender is characteristic of
the sporadic form of WHIM [1, 4, 8, 19]. The clinical
course is rather mild and neutropenia is the main recog-
nized and diagnosed symptom. The rarity of WHIM syn-
drome and the clinical variations in the combinations of
symptoms (e.g. warts observed in the second decade
and absent in children) are associated with the delay in
the correct diagnosis. The possibility of infection-
-derived mobilization of neutrophils and good response
to G-CSF and antibiotics in the majority of patients pre-
vents a life-threatening course of infections. Women
with WHIM syndrome may have normal pregnancy and
delivery, but whether the children are affected depends
on the type of heredity of WHIM syndrome. 
To summarize, we have presented a case of sporadic
WHIM syndrome in a young woman whose both sons
also turned out to have inherited the same mutation.
The diagnosis was made in the perinatal period by
genetic analysis of the CXCR4 gene in cord blood cells.
Despite significant progress in genetics and pathophysi-
ology, the diagnosis of WHIM may still depend on care-
ful observation of cytological features of defective
hematopoiesis in patients with clinical symptoms of
immunodeficiency with neutropenia. It is suggested that
perinatal diagnostics of WHIM syndrome based on
a molecular DNA analysis of cord blood cells should be
performed in cases of pregnancy of affected mothers.
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Fig. 3. Analysis of the CD14+CD16+ and CD14++CD16– subpopulations of monocytes. The gate was first set on a “CD45 vs. Side Scatter”
dot plot around the CD45-positive monocytes and adjacent lymphocytes (data not shown). These cells were then gated to exclude the
CD14–HLA-DR– NK cell population (A) and finally analyzed with respect to CD14 and CD16 antigen expression (B). Analyses of a typical
healthy adult (B) and healthy child (D) as well as the mother with WHIM syndrome (C) and her first son (E) are shown.
359 cells/µl
1 cell/µl
59 cells/µl
65 cells/ l µ
10 cells/µl
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